Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
Cleve Clin J Med
.
2023 Oct 2;90(10):603-605.
doi: 10.3949/ccjm.90a.23040.
Authors
Simran Gupta
1
,
Ayan Sen
2
,
Aman Verma
3
Affiliations
1
Division of Infectious Disease, Massachusetts General Hospital, Boston, MA sgupta@mgh.harvard.edu.
2
Chair, Department of Critical Care Medicine, Mayo Clinic Arizona, Phoenix, AZ.
3
Assistant Professor, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ.
PMID:
37783502
DOI:
10.3949/ccjm.90a.23040
No abstract available
MeSH terms
Administration, Intravenous
Humans
Midodrine* / therapeutic use
Retrospective Studies
Shock, Septic* / drug therapy
Vasoconstrictor Agents / therapeutic use
Substances
Midodrine
Vasoconstrictor Agents